Hirata et al. showed that MALAT1 interacts with EZH2, the catalytic subunit of PRC2, and that both MALAT1 and EZH2 are required for the EMT in renal cell carcinoma [69]. This evidence concerns the gene MALAT1 and hereditary clear cell renal cell carcinoma.